In vivo growth inhibition of head and neck squamous cell carcinoma by the Interferon-inducible gene IFI16

Cancer Letters

Volumn 287, Issue 1, 2010, Pages 33-43

  Mazibrada, Jasenka ^a   Andrea, Marco De ^a,b   Rittà, Massimo ^a,b   Borgogna, Cinzia ^b   dell'Eva, Raffaella ^c   Pfeffer, Ulrich ^c   Chiusa, Luigi ^a   Gariglio, Marisa ^b   Landolfo, Santo ^a  

^a UNIVERSITY OF TURIN   (Italy)

^b Amedeo Avogadro University   (Italy)

^c UNIVERSITY OF GENOA   (Italy)

Author keywords

Growth arrest; Head and neck squamous cell carcinoma; IFI16; In vivo tumorigenesis; Interferon

Indexed keywords

ANTINEOPLASTIC AGENT; CYTOKINE; INTERFERON INDUCIBLE PROTEIN 6; UNCLASSIFIED DRUG;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER GENE THERAPY; CANCER INHIBITION; CARCINOGENESIS; CELL GROWTH; CELL INFILTRATION; CONTROLLED STUDY; GENE EXPRESSION; HEAD AND NECK CARCINOMA; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; INFLAMMATION; INFLAMMATORY CELL; MACROPHAGE; MOLECULAR MECHANICS; MORPHOMETRICS; MOUSE; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; TUMOR NECROSIS; TUMOR VASCULARIZATION; TUMOR XENOGRAFT; WESTERN BLOTTING;

ANIMALS; ANTIGENS, CD; ANTIGENS, CD14; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; HEAD AND NECK NEOPLASMS; HUMANS; IMMUNOHISTOCHEMISTRY; MICE; NECROSIS; NUCLEAR PROTEINS; PHOSPHOPROTEINS;

EID: 72049113825     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2009.05.035     Document Type: Article

References (37)

1. Landolfo S., Gariglio M., Gribaudo G., and Lembo D. The Ifi 200 genes: an emerging family of IFN-inducible genes. Biochimie 80 (1998) 721-728
2. Ludlow L.E., Johnstone R.W., and Clarke C.J. The HIN-200 family: more than interferon-inducible genes?. Exp. Cell. Res. 308 (2005) 1-17
3. Aglipay J.A., Lee S.W., Okada S., Fujiuchi N., Ohtsuka T., Kwak J.C., Wang Y., Johnstone R.W., Deng C., Qin J., and Ouchi T. A member of the Pyrin family, IFI16, is a novel BRCA1-associated protein involved in the p53-mediated apoptosis pathway. Oncogene 22 (2003) 8931-8938
4. Dalal K., and Pio F. Thermodynamics and stability of the PAAD/DAPIN/PYRIN domain of IFI-16. FEBS Lett. 580 (2006) 3083-3090
5. Bertin J., and DiStefano P.S. The PYRIN domain: a novel motif found in apoptosis and inflammation proteins. Cell Death Differ. 7 (2000) 1273-1274
6. Inohara N., and Nunez G. NODs: intracellular proteins involved in inflammation and apoptosis. Nat. Rev. Immunol. 3 (2003) 371-382
7. Asefa B., Klarmann K.D., Copeland N.G., Gilbert D.J., Jenkins N.A., and Keller J.R. The interferon-inducible p200 family of proteins: a perspective on their roles in cell cycle regulation and differentiation. Blood Cells Mol. Dis. 32 (2004) 155-167
8. Johnstone R.W., and Trapani J.A. Transcription and growth regulatory functions of the HIN-200 family of proteins. Mol. Cell. Biol. 19 (1999) 5833-5838
9. Choubey D., Li S.J., Datta B., Gutterman J.U., and Lengyel P. Inhibition of E2F-mediated transcription by p202. Embo J. 15 (1996) 5668-5678
10. Datta B., Min W., Burma S., and Lengyel P. Increase in p202 expression during skeletal muscle differentiation: inhibition of MyoD protein expression and activity by p202. Mol. Cell. Biol. 18 (1998) 1074-1083
11. Ma X.Y., Wang H., Ding B., Zhong H., Ghosh S., and Lengyel P. The interferon-inducible p202a protein modulates NF-kappaB activity by inhibiting the binding to DNA of p50/p65 heterodimers and p65 homodimers while enhancing the binding of p50 homodimers. J. Biol. Chem. 278 (2003) 23008-23019
12. Dawson M.J., Trapani J.A., Briggs R.C., Nicholl J.K., Sutherland G.R., and Baker E. The closely linked genes encoding the myeloid nuclear differentiation antigen (MNDA) and IFI16 exhibit contrasting haemopoietic expression. Immunogenetics 41 (1995) 40-43
13. Trapani J.A., Browne K.A., Dawson M.J., Ramsay R.G., Eddy R.L., Show T.B., White P.C., and Dupont B. A novel gene constitutively expressed in human lymphoid cells is inducible with interferon-gamma in myeloid cells. Immunogenetics 36 (1992) 369-376
14. Gariglio M., Azzimonti B., Pagano M., Palestro G., De Andrea M., Valente G., Voglino G., Navino L., and Landolfo S. Immunohistochemical expression analysis of the human interferon-inducible gene IFI16, a member of the HIN200 family, not restricted to hematopoietic cells. J. Interferon Cytokine Res. 22 (2002) 815-821
15. Wei W., Clarke C.J., Somers G.R., Cresswell K.S., Loveland K.A., Trapani J.A., and Johnstone R.W. Expression of IFI 16 in epithelial cells and lymphoid tissues. Histochem. Cell Biol. 119 (2003) 45-54
16. Gugliesi F., Mondini M., Ravera R., Robotti A., de Andrea M., Gribaudo G., Gariglio M., and Landolfo S. Up-regulation of the interferon-inducible IFI16 gene by oxidative stress triggers p53 transcriptional activity in endothelial cells. J. Leukoc. Biol. 77 (2005) 820-829
17. Raffaella R., Gioia D., De Andrea M., Cappello P., Giovarelli M., Marconi P., Manservigi R., Gariglio M., and Landolfo S. The interferon-inducible IFI16 gene inhibits tube morphogenesis and proliferation of primary, but not HPV16 E6/E7-immortalized human endothelial cells. Exp. Cell Res. 293 (2004) 331-345
18. Mondini M., Vidali M., De Andrea M., Azzimonti B., Airo P., D'Ambrosio R., Riboldi P., Meroni P.L., Albano E., Shoenfeld Y., Gariglio M., and Landolfo S. A novel autoantigen to differentiate limited cutaneous systemic sclerosis from diffuse cutaneous systemic sclerosis: the interferon-inducible gene IFI16. Arthritis Rheum. 54 (2006) 3939-3944
19. Mondini M., Vidali M., Airo P., Riboldi D.E.A.M.P., Meroni P.L., Gariglio M., and Landolfo S. Role of the Interferon-inducible gene IFI16 in the etiopathogenesis of systemic autoimmune disorders. Ann. NY Acad. Sci. 1110 (2007) 47-56
20. Hakansson P., Segal D., Lassen C., Gullberg U., Morse III H.C., Fioretos T., and Meltzer P.S. Identification of genes differentially regulated by the P210 BCR/ABL1 fusion oncogene using cDNA microarrays. Exp. Hematol. 32 (2004) 476-482
21. De Andrea M., Gioia D., Mondini M., Azzimonti B., Reno F., Pecorari G., Landolfo V., Tommasino M., Accardi R., Herold-Mende C., Landolfo S., and Gariglio M. Effects of IFI16 overexpression on the growth and doxorubicin sensitivity of head and neck squamous cell carcinoma-derived cell lines. Head Neck 29 (2007) 835-844
22. Fujiuchi N., Aglipay J.A., Ohtsuka T., Maehara N., Sahin F., Su G.H., Lee S.W., and Ouchi T. Requirement of IFI16 for the maximal activation of p53 induced by ionizing radiation. J. Biol. Chem. 279 (2004) 20339-20344
23. Zhang Y., Howell R.D., Alfonso D.T., Yu J., Kong L., Wittig J.C., and Liu C.J. IFI16 inhibits tumorigenicity and cell proliferation of bone and cartilage tumor cells. Front. Biosci. 12 (2007) 4855-4863
24. Xin H., Curry J., Johnstone R.W., Nickoloff B.J., and Choubey D. Role of IFI 16, a member of the interferon-inducible p200-protein family, in prostate epithelial cellular senescence. Oncogene 22 (2003) 4831-4840
25. Azzimonti B., Pagano M., Mondini M., De Andrea M., Valente G., Monga G., Tommasino M., Aluffi P., Landolfo S., and Gariglio M. Altered patterns of the interferon-inducible gene IFI16 expression in head and neck squamous cell carcinoma: immunohistochemical study including correlation with retinoblastoma protein, Human papillomavirus infection and proliferation index. Histopathology 45 (2004) 560-572
26. Twentyman P.R., and Luscombe M. A study of some variables in a tetrazolium dye (MTT) based assay for cell growth and chemosensitivity. Brit. J. Cancer 56 (1987) 279-285
27. Aksamit R.R., Falk W., and Leonard EJ. Chemotaxis by mouse macrophage cell lines. J. Immunol. 126 (1981) 2194-2199
28. Caposio P., Gugliesi F., Zannetti C., Sponza S., Mondini M., Medico E., Hiscott J., Young H.A., Gribaudo G., Gariglio M., and Landolfo S. A novel role of the Interferon-inducible protein IFI16 as inducer of proinflammatory molecules in endothelial cells. J. Biol. Chem. 282 (2007) 33515-33529
29. Kirkiles-Smith N.C., Harding M.J., Shepherd B.R., Fader S.A., Yi T., Wang Y., McNiff J.M., Snyder E.L., Lorber M.I., Tellides G., and Pober J.S. Development of a humanized mouse model to study the role of macrophages in allograft injury. Transplantation 87 (2009) 189-197
30. Ninck S., Reisser C., Dyckhoff G., Helmke B., Bauer H., and Herold-Mende C. Expression profiles of angiogenic growth factors in squamous cell carcinomas of the head and neck. Int. J. Cancer 106 (2003) 34-44
31. Ouchi M., and Ouchi T. Role of IFI16 in DNA damage and checkpoint. Front. Biosci. 13 (2008) 236-239
32. Alimirah F., Chen J., Davis F.J., and Choubey D. IFI16 in human prostate cancer. Mol. Cancer Res. 5 (2007) 251-259
33. Hertel L., Rolle S., De Andrea M., Azzimonti B., Osello R., Gribaudo G., Gariglio M., and Landolfo S. The retinoblastoma protein is an essential mediator that links the Interferon-inducible 204 gene to cell-cycle regulation. Oncogene 19 (2000) 3598-3608
34. Kelly M., Hwang J.M., and Kubes P. Modulating leukocyte recruitment in inflammation. J. Allergy Clin. Immunol. 120 (2007) 3-10
35. Ley K., Laudanna C., Cybulsky M.I., and Nourshargh S. Getting to the site of inflammation: the leukocyte adhesion cascade updated. Nat. Rev. Immunol. 7 (2007) 678-689
36. Martin J., Collot-Teixeira S., McGregor L., and McGregor J.L. The dialogue between endothelial cells and monocytes/macrophages in vascular syndromes. Curr. Pharm. Des. 13 (2007) 1751-1759
37. Talmadge J.E., Donkor M., and Scholar E. Inflammatory cell infiltration of tumors: Jekyll or Hyde. Cancer Metastasis Rev. 26 (2007) 373-400